MustGrow Biologics Chief Executive Officer Corey Giasson joined Steve Darling from Proactive to reveal the signing of an exclusive distribution agreement with G.S. Long for the distribution of MustGrow's TerraSante biofertility product in Oregon and Washington State. TerraSante, certified organic by the USDA National Organic Program, is designed to enhance soil microbiome health, improve nutrient and water use efficiencies, and boost plant yields.

G.S. Long Co., Inc. has exclusive distribution rights for MustGrow's TerraSanteTM biofertility product in Oregon and Washington State.

Saskatoon, Saskatchewan--(Newsfile Corp. - April 17, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 9:30 AM (Local Time - PST). Colin Bletsky, MustGrow's COO, will be hosting the presentation and answering questions at the conclusion. One-on-one meetings will be held the following day, Thursday, May 2, 2024.

MustGrow has received The State of Oregon Agriculture approval to commence sales of TerraSanteTM, an organic biofertility product, in Oregon State.

Saskatoon, Saskatchewan--(Newsfile Corp. - December 13, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") wishes to provide additional information about the collaboration agreement (the "Agreement") with Bayer AG ("Bayer") which was announced December 11, 2023. The Agreement is a license and collaboration agreement enabling Bayer to further evaluate certain soil applications of MustGrow's mustard-based biocontrol technologies and to develop, formulate and commercialize licensed products containing such technologies for soil-applied, in-field uses for food and feed production in certain countries in Europe, the Middle East and Africa. The Agreement is dated effective December 11, 2023, and unless terminated earlier as provided in the Agreement, the term of the agreement shall continue until the expiration of all intellectual property licensed to Bayer under the agreement.

MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has signed a collaboration agreement with Bayer AG that focuses on the soil applications of MustGrow's mustard-based biocontrol technologies across Europe, the Middle East, and Africa (EMEA).

Bayer's commercial license covers soil applications of MustGrow's mustard-based biocontrol technologies in Europe, Middle East and Africa.

Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Harbor Access Global SMID Virtual Investor Conference, held November 16th are now available for online viewing....

MustGrow Biologics chief executive officer Corey Giasson joined Steve Darling from Proactive to share news regarding the approval of TerraSante crop fertilizer and soil amendment products by the Washington State Department of Agriculture.

Washington State Department of Agriculture Fertilizer Registration Certificate received to commence sales of TerraSanteTM crop fertilizer and soil amendment product in Washington State.

Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Harbor Access Global SMID Virtual Investor Conference to be held on November 16th, 2023. Individual investors, institutional...

The Company invites market participants to attend in online at VirtualInvestorConferences.com

Approval from Health Canada's Pest Management Regulatory Agency (PMRA) to commence large-scale farmer trials.

MustGrow Biologics chief operating officer Colin Bletsky joined Steve Darling from Proactive to share significant news the company’s Terrasante crop fertilizer and soil amendment technology has received USDA organic approval, marking a noteworthy achievement in the field of organic agricultural products.

USDA National Organic Program (OMRI Listed®) has awarded MustGrow's TerraSanteTM Crop Fertilizer and Soil Amendment technology with organic compliance.

Saskatoon, Saskatchewan--(Newsfile Corp. - October 19, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") will be participating in next week's Annual Biocontrol Industry Meeting ("ABIM") in Basel, Switzerland from October 23rd to 25th. ABIM is regarded as the premier event in the biocontrol industry. From policy makers, to farmers, to the end product users, global agriculture professionals attend ABIM each year to drive the sustainable agriculture industry forward.

Saskatoon, Saskatchewan--(Newsfile Corp. - September 12, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the engagement of Harbor Access LLC ("Harbor Access") to perform investor relations services and activities, as defined in accordance with the policies of the TSX Venture Exchange ("TSXV") and applicable securities laws.

Saskatoon, Saskatchewan--(Newsfile Corp. - September 6, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), and Janssen PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) ("Janssen PMP") are pleased to announce a significant expansion to their existing Exclusive Evaluation and Option Agreement (the "Agreement") to test and develop MustGrow's biological mustard plant-based technologies for certain postharvest food preservation storage applications globally. The Agreement will now also include postharvest potatoes and bananas globally.

Saskatoon, Saskatchewan--(Newsfile Corp. - September 1, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), today announced that the board of directors of the Company authorized and approved the grant of a total of 612,757 deferred share units ("DSUs") and 177,035 restricted share units ("RSUs") to certain directors, officers, and consultants of the Company, effective August 31, 2023. This grant of DSUs and RSUs is made pursuant to the Company's Omnibus Equity Incentive Plan (the "Plan").

Annual Awards Program Recognizes Innovation in Agricultural and Food Technologies Around the Globe

Saskatoon, Saskatchewan--(Newsfile Corp. - June 29, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the results of its 2023 annual meeting of shareholders (the "Meeting") held on June 29, 2023. At the Meeting, shareholders approved the setting of the number of directors of the Company at seven and all director nominees listed in the Company's management information circular dated May 31, 2023 were elected as directors of the Company on a vote held by ballot. The results of the ballot were as follows:

MustGrow Biologics President and CEO Corey Giasson joins Natalie Stoberman from the Proactive newsrooms to share the company's successful completion of initial commercial run-rate production via a third-party contract manufacturer for its mustard plant-based extract.

Saskatoon, Saskatchewan--(Newsfile Corp. - June 13, 2023) -  MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the successful initial commercial run-rate production of its mustard plant-based biocontrol liquid via a contract manufacturer.

MustGrow CEO Colin Bletsky joins Natalie Stoberman from the Proactive studio to share details of its new agreement with Bio Ag Product Strategies for the development of technologies related to soil microbiome and soil health.

Saskatoon, Saskatchewan--(Newsfile Corp. - June 5, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the signing of a Contract Services Agreement (the "Agreement") with Oregon-based Bio Ag Product Strategies to develop and commercialize MustGrow's soil amendment and biofertility technologies, including TerraSanteTM. The Agreement is a non-exclusive contract, leaving MustGrow the ability to seek commercial collaborations and funding partnerships.

MustGrow Biologics CEO Colin Bletsky joins Natalie Stoberman from the Proactive newsroom to share how the company's partnership with Janssen PMP has added an exclusive evaluation to add further research to MustGrow's mustard plant-based technologies.

Saskatoon, Saskatchewan--(Newsfile Corp. - May 23, 2023) -  MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow"), and JANSSEN PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) ("Janssen PMP") have signed an extension to the Exclusive Evaluation and Option Agreement (the "Agreement") to test and develop MustGrow's biological mustard plant-based technologies for certain postharvest food preservation storage applications globally.

Saskatoon, Saskatchewan--(Newsfile Corp. - April 24, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), announces that it will be hosting an investor webcast on Wednesday, April 26th at 4:00pm ET. MustGrow's management team will be presenting on recent corporate progress, biological industry developments, and upcoming catalysts. The presentation will be followed by an audience Q&A session.

Saskatoon, Saskatchewan--(Newsfile Corp. - April 18, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to report an additional area of sustainable agriculture opportunity that the Company will be pursuing in the soil amendment ("Soil Amendment") and biofertility ("Biofertility") marketplaces. MustGrow's Soil Amendment and Biofertility development programs will focus on soil and soil microbiome health, nutrient and water use efficiencies, and plant yields.

MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has seen its portfolio of patents grow exponentially.

Saskatoon, Saskatchewan--(Newsfile Corp. - March 8, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to report on the growth of its intellectual property portfolio (the "IP Portfolio") in both quantity and scope, particularly with respect to the Company's patents.

Saskatoon, Saskatchewan--(Newsfile Corp. - November 9, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce that the TSX Venture Exchange ("TSXV") has approved the Company's application to list its common shares (the "Shares") on the TSXV. The Shares will commence trading on the TSXV under the ticker symbol "MGRO" at the opening of the Market on November 11, 2022. Shareholders will not be required to take any action in connection with MustGrow's listing on the TSXV. The Shares will also continue to be listed on the OTCQB Marketplace in the United States under the symbol "MGROF" and on the Frankfurt Stock Exchange under the symbol "0C0".

Saskatoon, Saskatchewan--(Newsfile Corp. - October 11, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce that it has received conditional approval to list its common shares on the TSX Venture Exchange (the "TSXV"). The listing is subject to the Company fulfilling certain requirements of the TSXV in accordance with the terms of its conditional approval letter dated October 6, 2022.

Saskatoon, Saskatchewan--(Newsfile Corp. - September 15, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), and its global agriculture partners continue to drive MustGrow's organic mustard-derived crop protection and food preservation technology forward through field trials, development work and regulatory approval strategies in key global agricultural regions. Publicly-disclosed programs include:

Tokyo, Japan and Saskatoon, Saskatchewan--(Newsfile Corp. - August 17, 2022) - Sumitomo Corporation (TYO: 8053) (OTC: SSUMY) and MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") have signed an extension to their Exclusive Evaluation and Option Agreement (the "Extension Agreement") to continue developing MustGrow's mustard-based technology across the Americas.

Collaboration expands innovative, sustainable and regenerative farming solutions for Canadian growers

MustGrow Biologics Corp. (CSE: MGRO, OTC: MGROF, FRA: 0C0) ("MustGrow" or the "Company") announces that it has filed a final short form base shelf prospectus (the "Shelf Prospectus") with securities regulatory authorities in each province of...

Saskatoon, Saskatchewan--(Newsfile Corp. - April 20, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow"), and JANSSEN PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) ("Janssen PMP") have signed an Exclusive Evaluation and Option Agreement (the "Agreement") to test and develop MustGrow's biological mustard plant-based technologies for certain postharvest food preservation storage applications globally.

Saskatoon, Saskatchewan--(Newsfile Corp. - March 15, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce the appointment of Ms. Laura Westby, Senior Vice President - Legal and Intellectual Property at Invaio Sciences, to its Board of Directors. Ms. Westby will leverage her extensive business and legal experience in international agriculture, specifically around commercial arrangements, strategy and intellectual property.

Saskatoon, Saskatchewan--(Newsfile Corp. - March 2, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow"), is pleased to provide an update of its organic mustard plant-derived crop protection technology pipeline. MustGrow has harnessed the mustard seed's natural defense mechanism for treatment of diseases, pests, and weeds.

Saskatoon, Saskatchewan--(Newsfile Corp. - February 24, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow"), an agriculture biotechnology company focused on providing organic biological crop protection solutions, announces an investor webcast to discuss its two major global partnerships with leading agriculture companies.

Saskatoon, Saskatchewan--(Newsfile Corp. - February 9, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce successful postharvest trials in both disease control and sprout suppression of stored potatoes conducted by a third-party independent laboratory. MustGrow's organic mustard plant-based technology outperformed leading synthetic chemical standards for treatment of stored potatoes for both Fusarium dry rot disease and sprouting. No combination solutions currently exist that treat both disease and sprouting - making MustGrow's application unique in addressing both postharvest issues in potatoes simultaneously.

Saskatoon, Saskatchewan--(Newsfile Corp. - January 21, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") and Bayer have signed an Exclusive Agreement to evaluate MustGrow's biological technologies to determine efficacy and commercial potential in key agricultural regions. Sustainable innovations and green technologies are necessary to ensure agricultural production continues to address food safety and security as well as soil health. This agreement between Bayer and MustGrow further demonstrates the importance of innovation in sustainable technologies in agricultural regions around the world.

VANCOUVER, BC, Jan. 21, 2022 /CNW/ - Trading resumes in:

VANCOUVER, BC, Jan. 20, 2022 /CNW/ - The following issues have been halted by IIROC:

Saskatoon, Saskatchewan--(Newsfile Corp. - December 14, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow"), working with Sumitomo Corporation (TYO: 8053) (OTC: SSUMY), is pleased to announce its successful initial field trial program in the US. MustGrow and Sumitomo Corporation are now expanding into multiple countries and new crop categories, with Sumitomo Corporation driving field trial development and regulatory work necessary for commercialization in several countries in the Americas.

Saskatoon, Saskatchewan--(Newsfile Corp. - November 10, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce the success of its initial field trial program in Colombia. Field testing confirmed the efficacy of MustGrow's mustard plant-derived biopesticide in treating the disease Fusarium wilt TR4 - a unique feat MustGrow believes no other agri-science team has achieved. Fusarium wilt TR4 (often referred to as the Panama Disease) is a devastating pathogen ravaging the $25 billion global banana industry.

Saskatoon, Saskatchewan--(Newsfile Corp. - November 4, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness of its natural mustard plant-based crop protection technologies.

Saskatoon, Saskatchewan--(Newsfile Corp. - October 7, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce the closing of its previously-announced non-brokered private placement (the "Private Placement"). MustGrow has closed on an aggregate of 2,726,611 units for gross proceeds of C$7,089,189 effective October 6, 2021. Included in this sum, Ira Gluskin and Gluskin-related parties have invested C$1.0 million under the same terms and conditions.

Saskatoon, Saskatchewan--(Newsfile Corp. - September 29, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce it has upsized its previously-announced C$2.0 million non-brokered private placement (the "Private Placement") to approximately 2.7 million units (each a "Unit") for gross proceeds of approximately C$6.9 million at a price per Unit of C$2.60. Ira Gluskin and Gluskin-related parties have subscribed to invest C$1.0 million in the Private Placement under the same terms and conditions.

Saskatoon, Saskatchewan--(Newsfile Corp. - September 13, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) ("MustGrow") is pleased to announce a non-brokered private placement (the "Private Placement") of approximately 770,000 units (each a "Unit") for gross proceeds of approximately C$2.0 million at a price per Unit of C$2.60.

VANCOUVER, BC, Aug. 4, 2021 /CNW/ - Trading resumes in:

Saskatoon, Saskatchewan--(Newsfile Corp. - August 4, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") and Sumitomo Corporation (TYO: 8053) (OTC: SSUMY) have signed an Exclusive Evaluation and Option Agreement (the "Agreement") to evaluate MustGrow's technology for purposes of determining efficacy and commercial potential.

VANCOUVER, BC, Aug. 3, 2021 /CNW/ - The following issues have been halted by IIROC:

Saskatoon, Saskatchewan--(Newsfile Corp. - May 12, 2021) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce successful greenhouse efficacy results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores ("Aphanomyces") via an independent third party. Control in greenhouse soil was recorded across a range of economic application rates. MustGrow will advance to larger scale field tests in 2021 to be conducted under the recently-announced collaborative Canadian field trials program with NexusBioAg, a division of Univar Solutions Inc. Study results and applicability are patent-protected under MustGrow's existing suite of issued patents.

Saskatoon, Saskatchewan--(Newsfile Corp. - May 4, 2021) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the "Company", "MustGrow"), an agriculture technology company focused on providing natural biological crop protection solutions, will discuss (via live webcast) recent achievements and upcoming catalysts.

Saskatoon, Saskatchewan--(Newsfile Corp. - April 29, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") and Univar Canada Ltd.'s NexusBioAg ("NexusBioAg"), a division of Univar Solutions Inc., are pleased to announce a collaborative field trial program in Canada (the "Field Trials"). NexusBioAg will conduct the Field Trials of MustGrow's mustard-derived biopesticide, TerraMG, (the "Product", or "Products") for treatment of Clubroot and Aphanomyces diseases in Canola and Pulse Crops, respectively.

Saskatoon, Saskatchewan--(Newsfile Corp. - April 22, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to outline its environmentally-sustainable approach to crop protection on Earth Day.

Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics for the month of March 2021. Trading volume was the fourth highest monthly level on record, while trading value was the second highest. The total capital raised by CSE issuers in the first three months of the year was approximately $3.2 billion, compared to $3.7 billion raised in all of 2020.

Saskatoon, Saskatchewan--(Newsfile Corp. - April 15, 2021) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness of its natural mustard plant-based biopesticide technologies.

Saskatoon, Saskatchewan--(Newsfile Corp. - April 12, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce successful field trial studies comparing MustGrow's mustard plant-based biopesticide versus one of the leading soil fumigation synthetic chemicals, Chloropicrin 100 band ("Chloropicrin"). As previously reported in June 2020, MustGrow's tobacco crop protection program is being funded by and conducted through a 3rd party research organization ("3rd PRO").

Saskatoon, Saskatchewan--(Newsfile Corp. - March 3, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce that it has isolated and concentrated an additional molecule, thiocyanate, from mustard seed. Thiocyanate, which is responsible for the systemic activity behind the mustard plant's natural herbicidal (weed-killer) properties, is the third molecule from mustard seed that MustGrow has isolated, extracted, and concentrated. MustGrow had previously reported herbicidal proof-of-concept success without isolating thiocyanate and now expects to build on those studies with this additional herbicidal mode-of-action now identified.

NEW YORK, Feb. 12, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced MustGrow Biologics Corp. (CSE: MGRO; OTCQX: MGROF; FRA; 0C0) ("MustGrow") an agricultural biotech company, has qualified to trade on the OTCQX® Best Market. MustGrow upgraded to OTCQX from the OTCQB® Venture Market.

Saskatoon, Saskatchewan--(Newsfile Corp. - February 9, 2021) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce further laboratory results of its mustard-derived natural biopesticide on the disease Fusarium wilt TR4 ("Fusarium wilt TR4"). Fusarium wilt TR4 (previously referred to as the Panama Disease) is a devastating pathogen ravaging the $25 billion global banana industry. Testing and reporting in this second Colombia study was completed by a different third party independent laboratory than was used in the first study to add further validation.

Saskatoon, Saskatchewan--(Newsfile Corp. - February 2, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce its upcoming awareness initiatives. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness of its natural mustard plant-based crop protection products.

Saskatoon, Saskatchewan--(Newsfile Corp. - January 19, 2021) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to report third party confirmatory studies that the active ingredient in MustGrow's mustard plant-based technology, Allyl Isothiocyanate ("AITC"), has a positive impact on soil health, contributing to the environmental and ecological security of both our plant-based food supply and the planet. Application of natural AITC returns organic plant material to the soil through its pre-plant treatment process as a potential alternative to using synthetic chemicals.

Saskatoon, Saskatchewan--(Newsfile Corp. - January 14, 2021) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce that it has received over C$1.5 million from the exercise of approximately 3.2 million common share purchase warrants at an average weighted exercise price of C$0.48 per share. The Company intends to use the proceeds of the warrant exercise to advance its organic mustard plant-based crop protection technologies and for general working capital purposes. MustGrow has harnessed the mustard seed's natural defense mechanism to control diseases, pests, and weeds with a natural food-grade biopesticide.

Saskatoon, Saskatchewan--(Newsfile Corp. - December 14, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce the appointment of Mr. David M. Borecky, Vice President and Chief Accounting Officer of Impossible Foods to its Board of Directors. David will leverage his extensive global relationships in the plant-based innovation community to accelerate and raise awareness of MustGrow's remarkably safe and effective plant-based crop protection technologies.

Saskatoon, Saskatchewan--(Newsfile Corp. - December 9, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to provide an overview of its natural plant-based mustard-derived biopesticide technology product pipeline. MustGrow has harnessed the mustard seed's natural defense mechanism to develop and commercialize biopesticide technologies to control diseases, pests and weeds.

Saskatoon, Saskatchewan--(Newsfile Corp. - December 7, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow"), an agriculture biotech company focused on providing natural biological crop protection for high value crops, announces the following live webcast for its investment community.

Saskatoon, Saskatchewan--(Newsfile Corp. - December 1, 2020) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce the initial Colombia laboratory test results of MustGrow's mustard-derived organic biopesticide formulation on the disease Fusarium wilt TR4 ("Fusarium wilt TR4"), a devastating pathogen ravaging the $25 billion global banana industry - in the past referred to as the Panama Disease. Testing and reporting was completed via third party independent laboratory CyberAgrot SAS in Colombia using Instituto Colombiano Agropecuario (ICA) official protocols.

Saskatoon, Saskatchewan--(Newsfile Corp. - November 24, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness of its remarkable natural mustard-derived crop protection products.

Saskatoon, Saskatchewan--(Newsfile Corp. - November 23, 2020) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce the exclusive patent licensing from the University of Idaho pertaining to a natural biopesticide mustard-based treatment of stored produce and other foods, particularly sprout suppression of potatoes.

Saskatoon, Saskatchewan--(Newsfile Corp. - October 7, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce the following conference schedule. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness of its remarkable natural mustard-derived crop protection products.

Saskatoon, Saskatchewan--(Newsfile Corp. - September 29, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) (the "Company", "MustGrow") announces the commencement of testing of MustGrow's proprietary TerraMG bio-pesticide formulation on the Panama Disease (Fusarium wilt TR4), a devastating disease pathogen ravaging the $25 billion global banana industry. MustGrow's TerraMG bio-pesticide has been proven to control soil-borne diseases similar to Panama Disease.

Saskatoon, Saskatchewan--(Newsfile Corp. - September 17, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce the appointment of seasoned global social impact financier Barry Palte to its advisory team. Barry will leverage his extensive global relationships in sustainable and innovative ag-tech to support the global rollout of MustGrow's remarkably safe and effective mustard-derived crop protection products.

Saskatoon, Saskatchewan--(Newsfile Corp. - August 26, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce successful greenhouse soil test results of its patented mustard-derived bio-pesticide on clubroot resting spores (Plasmodiophora brassicae) ("Clubroot"). With successful greenhouse soil efficacy, MustGrow will advance to larger scale Clubroot field tests in 2021. Study results and applicability are patent-protected under MustGrow's existing suite of issued patents.

Saskatoon, Saskatchewan--(Newsfile Corp. - August 12, 2020) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (the "Company", "MustGrow") announces successful proof-of-concept for its proprietary biological non-selective bio-herbicide, based on MustGrow's signature mustard-derived approach to controlling unwanted pests and diseases.

Saskatoon, Saskatchewan--(Newsfile Corp. - August 6, 2020) -  MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, is pleased to provide a corporate update for its stakeholders. For MustGrow, 2020 has been an execution story which includes key achievements for patents, crop protection and international expansion. Chief Executive Officer Corey Giasson outlines its industry landscape, recent achievements, and near-term catalysts. The agricultural industry and investment capital flow is transitioning towards sustainable, natural, biological, and environmentally friendly farming practices. With an evolving regulatory backdrop seemingly tailor-made to develop organic bio-pesticides and bio-herbicides, MustGrow is poised to capitalize in 2020.

 

Saskatoon, Saskatchewan--(Newsfile Corp. - June 3, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, is pleased to announce the commencement of a tobacco crop protection research program funded by the Canadian Tobacco Research Foundation to target tobacco cyst nematodes and root-lesion nematodes ("Nematodes").

Saskatoon, Sasktachewan--(Newsfile Corp. - May 27, 2020) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, is pleased to announce the laboratory test results of its patented mustard-derived bio-pesticide on clubroot spores ("Clubroot"). Clubroot is a rapidly-spreading disease pathogen destroying canola, one of Canada's more profitable crops.

SASKATOON, Saskatchewan, May 5, 2020 /CNW/ -- MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, is pleased to announce the initiation of its South American strategy for bio-pesticide registration of TerraMG for use in several crop groups.  TerraMG is MustGrow's signature mustard-derived liquid pre-plant bio-pesticide formulation that has been proven to control soil-borne pests and diseases such as Fusarium, Botrytis,

SASKATOON, Saskatchewan, May 5, 2020 /PRNewswire/ -- MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, is pleased to announce the initiation of its South American strategy for bio-pesticide registration of TerraMG for use in several crop groups.  TerraMG is MustGrow's signature mustard-derived liquid pre-plant bio-pesticide formulation that has been proven to control soil-borne pests and diseases such as Fusarium, Bo

Saskatoon, Saskatchewan--(Newsfile Corp. - May 1, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, has issued 1,050,000 common share options (each an "Option") to management and directors of the Company. Each Option shall entitle the holder to acquire one common share of the Company at a price of $0.34 exercisable until April 30, 2025. The terms of each Option, including vesting period (25% on date of grant and 25% on each anniversary) is in accordance with the Company's management and directors' stock option plan. MustGrow has also issued 1,400,000 common share purchase warrants (each a "Warrant") to a consultant of the Company. Each Warrant shall entitle the holder to acquire one common share of the Company at a price of $0.35 exercisable until April 2, 2022.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce that it has received approval...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, is pleased to announce the...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, is pleased to announce that it...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, today announced the launch of...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, will be attending the 10th...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, has issued 550,000 common share...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, is pleased to announce the...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, is pleased to announce its...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce it has closed its...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce it has increased the size of...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce a non-brokered private...

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce its intent to address a new...

Mustard-derived formulation improves efficacy and economics through concentration of the active ingredient in a liquid format.Efficacy Results: 100% control of hard-to-kill soil borne diseases such as Botrytis and Fusarium.Economic Feasibility: >-...

MustGrow Biologics Corp. (MGRO-CSE) (“MustGrow” or the “Company”), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides and bio-fertility products for the cannabis industry, is pleased...

MustGrow Biologics Corp. (MGRO-CSE) (“MustGrow” or the “Company”), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry, is pleased to announce a Supply and...

MustGrow Biologics Corp. (MGRO-CSE) (“MustGrow” or the "Company"), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry, is pleased to present its previous...

MustGrow Biologics Corp. (MGRO-CSE) (“MustGrow” or the "Company"), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry, is pleased to announce the...

via NetworkNewsAudio – MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and bio-fertilizers, today announces the broadcast of its exclusive audio interview...

Triangle Plant Sciences (“TPS”), a division of Verdesian Life Sciences of Cary, NC, has announced a partnership with MustGrow Biologics Corp. (“MustGrow”) of Saskatoon, SK, to offer exclusive Canada and global access to TPS’s TP-1000, the first...

Vancouver, British Columbia--(Newsfile Corp. - July 11, 2019) - MustGrow Biologics (CSE: MGRO) is one of the latest new listings on the Canadian Securities Exchange. MustGrow is an agricultural biotech company focused on developing and commercializing its patented natural biologic product that acts as a pesticide, fungicide nematicide and fertilizer. 

MustGrow Biologics Corp. (MGRO-CSE) (“MustGrow” or the "Company"), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry, is pleased to announce that a...

July 10 2019 - TheNewswire - On this edition of NewlyTrading, Corey Giasson, President and CEO of MustGrow Biologics Corp. (CSE:MGRO)

MustGrow Biologics Corp. (MGRO-CSE) (“MustGrow” or the "Company"), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers, is pleased to announce its common shares will commence...

MustGrow Biologics Corp. (MGRO-CSE) (the "Company", “MustGrow”), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers, is pleased to announce it has received approval from the...